ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,722, issued on May 6, was assigned to 2seventy bio Inc. (Cambridge, Mass.).

"Methods for manufacturing adoptive cell therapies" was invented by Richard Morgan (Center Harbor, N.H.), Kevin Friedman (Medford, Mass.) and Dawn Maier (North Reading, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for manufacturing adoptive cell therapies. In particular embodiments, the invention provides methods of harvesting populations of cells, isolating and activating PBMCs, expanding T cells, and administering the T cell therapeutic to a subject in need thereof."

The patent was filed on April 24, 2015, under Appl...